Evidence map›Paper›PMID 28981455›Full record

ArticleInternational journal of molecular sciences2017

A Unique TGFB1-Driven Genomic Program Links Astrocytosis, Low-Grade Inflammation and Partial Demyelination in Spinal Cord Periplaques from Progressive Multiple Sclerosis Patients.

Serge Nataf, Marc Barritault, Laurent Pays

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Myelinodegeneration vs. Neurodegeneration in MS Progressive Forms.International journal of molecular sciences · 2023
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis.International journal of molecular sciences · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Serge NatafUniv Lyon, CarMeN laboratory, Inserm U1060, INRA U1397, Université Claude Bernard Lyon 1, INSA Lyon, Charles Merieux Medical School, F-69600 Oullins, France. serge.nataf@inserm.fr.
Marc BarritaultUniv Lyon, Department of Cancer Cell Plasticity, Cancer Research Center of Lyon, INSERMU1052, CNRS UMR5286, University Claude Bernard Lyon 1, 151 Cours Albert Thomas, 69003 Lyon, France. laurent.pays@univ-lyon1.fr.
Laurent PaysUniv Lyon, CarMeN laboratory, Inserm U1060, INRA U1397, Université Claude Bernard Lyon 1, INSA Lyon, Charles Merieux Medical School, F-69600 Oullins, France. marc.barritault@chu-lyon.fr.
Hôpital Edouard Herriot · FRInserm · FRLaboratoire CarMeN · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported that, in multiple sclerosis (MS) patients with a progressive form of the disease, spinal cord periplaques extend distance away from plaque borders and are characterized by the co-occurrence of partial demyelination, astrocytosis and low-grade inflammation. However, transcriptomic analyses did not allow providing a comprehensive view of molecular events in astrocytes vs. oligodendrocytes. Here, we re-assessed our transcriptomic data and performed co-expression analyses to characterize astrocyte vs. oligodendrocyte molecular signatures in periplaques. We identified an astrocytosis-related co-expression module whose central hub was the astrocyte gene

Indexed as

AstrocytesCell Cycle ProteinsComputational BiologyConnexin 43Glial Fibrillary Acidic ProteinHumansInflammationInterleukin-12Interleukin-12 Subunit p35Interleukin-17Interleukin-33Intracellular Signaling Peptides and ProteinsLymphokinesMultiple SclerosisMyelin SheathN-myc Downstream-Regulated Gene 1 ProteinCell Cycle ProteinsConnexin 43Glial Fibrillary Acidic ProteinIL12A protein, humanIL17D protein, humanInterleukin-12Interleukin-12 Subunit p35Interleukin-17Interleukin-33Intracellular Signaling Peptides and ProteinsLymphokinesN-myc Downstream-Regulated Gene 1 ProteinPlatelet-Derived Growth Factorplatelet-derived growth factor CTransforming Growth Factor beta1astrocytesbioinformaticsmultiple sclerosismyelinneuroinflammation

Identifiers

PMID28981455
PMCPMC5666779
OpenAlexW2761826693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.